A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator’s Choi

A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator’s Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 (CLARITY-Gastric 01)

Abierta

Código protocolo: D9802C00001
Código EudraCT: 2023-508276-11
Grupo de investigación: Investigación Biomédica en Tumores del Aparato Digestivo
Servicio: Oncología
Investigador/a principal: Acosta Eyzaguirre, Daniel
Patología: Tumors
Fase: Fase III
Estado: Reclutando voluntarios